SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-051011
Filing Date
2022-09-22
Accepted
2022-09-22 16:11:49
Documents
2
Period of Report
2022-09-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4006
2 POA DOCUMENT poa.txt EX-24 3604
  Complete submission text file 0001209191-22-051011.txt   9004
Mailing Address C/O ADEONA PHARMACEUTICALS, INC 3930 VARSITY DRIVE ANN ARBOR MI 48108
Business Address
Riley Jeffrey Scott (Reporting) CIK: 0001487645 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40237 | Film No.: 221259356

Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Issuer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations